167 related articles for article (PubMed ID: 21542512)
1. A glimmer of hope for rural dialysis units.
Beyer L
Nephrol News Issues; 2011 Apr; 25(4):29. PubMed ID: 21542512
[No Abstract] [Full Text] [Related]
2. What can we expect down the road?
Sullivan J
Nephrol News Issues; 2011 Apr; 25(4):28-9. PubMed ID: 21542511
[No Abstract] [Full Text] [Related]
3. Will payment and quality-driven reform improve outcomes?
Neumann ME
Nephrol News Issues; 2012 Oct; 26(11):12. PubMed ID: 23427715
[No Abstract] [Full Text] [Related]
4. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
Gardner AV
Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
[No Abstract] [Full Text] [Related]
5. Erythropoietin & ESRD payments: a promising policy outcome?
Roe W
Nephrol News Issues; 1989 Sep; 3(9):34-5. PubMed ID: 2682270
[No Abstract] [Full Text] [Related]
6. Looking for a good story...
Coutts LR
Nephrol News Issues; 1999 Apr; 13(4):67, 70. PubMed ID: 10418453
[No Abstract] [Full Text] [Related]
7. Medicare and erythropoietin.
Steinbrook R
N Engl J Med; 2007 Jan; 356(1):4-6. PubMed ID: 17202449
[No Abstract] [Full Text] [Related]
8. Squeezing the inner-city dialysis dollar.
Kanter A
Nephrol News Issues; 1989 Nov; 3(11):24-6. PubMed ID: 2594108
[No Abstract] [Full Text] [Related]
9. Futuristic plans for ESRD--a new bundled payment system.
Michael M
Nephrol News Issues; 2005 Sep; 19(10):52, 54. PubMed ID: 16187649
[No Abstract] [Full Text] [Related]
10. Can we revitalize the ESRD program?
McFeeley T
Nephrol News Issues; 2004 Apr; 18(5):42-3, 47, 87. PubMed ID: 15125164
[No Abstract] [Full Text] [Related]
11. Who should be paying for vitamin D analogues--Medicare or the patients?
Hall G
Nephrol Nurs J; 2006; 33(3):345-6, 351. PubMed ID: 16859205
[No Abstract] [Full Text] [Related]
12. How dialysis is paid for: what the dialysis medical director should know, and why.
Deoreo PB
Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
[TBL] [Abstract][Full Text] [Related]
13. Bundling, and what is important for patients.
Eilers D; LeBeau K
Nephrol News Issues; 2009 Dec; 23(13):11. PubMed ID: 20050433
[No Abstract] [Full Text] [Related]
14. Medicare program; end-stage renal disease prospective payment system. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2010 Aug; 75(155):49029-214. PubMed ID: 20712086
[TBL] [Abstract][Full Text] [Related]
15. Helping patients with end-stage renal disease.
Kuchta K; VanBuskirk S; Houglum M
Am J Nurs; 2007 May; 107(5):35-6. PubMed ID: 17443073
[No Abstract] [Full Text] [Related]
16. Special treatment--the story of Medicare's ESRD entitlement.
Rettig RA
N Engl J Med; 2011 Feb; 364(7):596-8. PubMed ID: 21323539
[No Abstract] [Full Text] [Related]
17. Important legal, regulatory issues impacting renal care in 2008.
Riley J; Pristave R
Nephrol News Issues; 2008 Dec; 22(13):48-9. PubMed ID: 19149317
[No Abstract] [Full Text] [Related]
18. How will small providers fare under the bundle?
Lugo O
Nephrol News Issues; 2011 Apr; 25(4):30. PubMed ID: 21542513
[No Abstract] [Full Text] [Related]
19. Bundling and its potential impact on dialysis service providers.
Sullivan J
Nephrol News Issues; 2008 Oct; 22(11):12, 14, 16-7. PubMed ID: 19009855
[No Abstract] [Full Text] [Related]
20. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
